178 related articles for article (PubMed ID: 11486333)
1. Fractionated illumination for oesophageal ALA-PDT: effect on blood flow and PpIX formation.
van den Boogert J; van Staveren HJ; de Bruin RW; Siersema PD; van Hillegersberg R
Lasers Med Sci; 2001; 16(1):16-25. PubMed ID: 11486333
[TBL] [Abstract][Full Text] [Related]
2. Fractionated illumination in oesophageal ALA-PDT: effect on ferrochelatase activity.
van Den Boogert J; van Staveren HJ; de Bruin RWF ; de Rooij FWM ; Edixhoven-Bosdijk A; Siersema PD; van Hillegersberg R
J Photochem Photobiol B; 2000 Jun; 56(1):53-60. PubMed ID: 11073316
[TBL] [Abstract][Full Text] [Related]
3. Topical 5-aminolevulinic acid-photodynamic therapy of hairless mouse skin using two-fold illumination schemes: PpIX fluorescence kinetics, photobleaching and biological effect.
Robinson DJ; de Bruijn HS; de Wolf WJ; Sterenborg HJ; Star WM
Photochem Photobiol; 2000 Dec; 72(6):794-802. PubMed ID: 11140268
[TBL] [Abstract][Full Text] [Related]
4. Timing of illumination is essential for effective and safe photodynamic therapy: a study in the normal rat oesophagus.
van den Boogert J; van Hillegersberg R; van Staveren HJ; de Bruin RW; van Dekken H; Siersema PD; Tilanus HW
Br J Cancer; 1999 Feb; 79(5-6):825-30. PubMed ID: 10070876
[TBL] [Abstract][Full Text] [Related]
5. Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.
Kruijt B; de Bruijn HS; van der Ploeg-van den Heuvel A; de Bruin RW; Sterenborg HJ; Amelink A; Robinson DJ
Photochem Photobiol; 2008; 84(6):1515-27. PubMed ID: 18557821
[TBL] [Abstract][Full Text] [Related]
6. Protoporphyrin IX fluorescence photobleaching and the response of rat Barrett's esophagus following 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; Kluin J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2006; 82(6):1638-44. PubMed ID: 16879035
[TBL] [Abstract][Full Text] [Related]
7. The effect of light fractionation with a 2-h dark interval on the efficacy of topical hexyl-aminolevulinate photodynamic therapy in normal mouse skin.
Middelburg TA; de Bruijn HS; van der Ploeg-van den Heuvel A; Neumann HA; Robinson DJ
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):703-9. PubMed ID: 24284130
[TBL] [Abstract][Full Text] [Related]
8. Dose and timing of the first light fraction in two-fold illumination schemes for topical ALA-mediated photodynamic therapy of hairless mouse skin.
Robinson DJ; de Bruijn HS; Star WM; Sterenborg HJ
Photochem Photobiol; 2003 Mar; 77(3):319-23. PubMed ID: 12685661
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy using 5-aminolaevulinic acid for oesophageal adenocarcinoma associated with Barrett's metaplasia.
Tan WC; Fulljames C; Stone N; Dix AJ; Shepherd N; Roberts DJ; Brown SB; Krasner N; Barr H
J Photochem Photobiol B; 1999; 53(1-3):75-80. PubMed ID: 10672532
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic effectiveness and vasoconstriction in hairless mouse skin after topical 5-aminolevulinic acid and single- or two-fold illumination.
van der Veen N; Hebeda KM; de Bruijn HS; Star WM
Photochem Photobiol; 1999 Dec; 70(6):921-9. PubMed ID: 10628304
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy of human Barrett's cancer using 5-aminolaevulinic acid-induced protoporphyrin IX: an in-vivo dosimetry study in athymic nude mice.
Pech O; Nagy CD; Gossner L; May A; Ell C
Eur J Gastroenterol Hepatol; 2002 Jun; 14(6):657-62. PubMed ID: 12072600
[TBL] [Abstract][Full Text] [Related]
12. Monitoring in situ dosimetry and protoporphyrin IX fluorescence photobleaching in the normal rat esophagus during 5-aminolevulinic acid photodynamic therapy.
Boere IA; Robinson DJ; de Bruijn HS; van den Boogert J; Tilanus HW; Sterenborg HJ; de Bruin RW
Photochem Photobiol; 2003 Sep; 78(3):271-7. PubMed ID: 14556314
[TBL] [Abstract][Full Text] [Related]
13. Two course illuminating scheme improves aminolevulinic acid photodynamic therapy in cell cultures.
Hinnen P; Siersema PD; Edixhoven A; Wilson JH; de Rooij FW
Cell Mol Biol (Noisy-le-grand); 2002 Dec; 48(8):903-9. PubMed ID: 12699249
[TBL] [Abstract][Full Text] [Related]
14. Timing of 5-aminolaevulinic acid-induced photodynamic therapy for the treatment of patients with Barrett's oesophagus.
Hinnen P; de Rooij FW; Hop WC; Edixhoven A; van Dekken H; Wilson JH; Siersema PD
J Photochem Photobiol B; 2002 Aug; 68(1):8-14. PubMed ID: 12208031
[TBL] [Abstract][Full Text] [Related]
15. Increase in protoporphyrin IX after 5-aminolevulinic acid based photodynamic therapy is due to local re-synthesis.
de Bruijn HS; Kruijt B; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
Photochem Photobiol Sci; 2007 Aug; 6(8):857-64. PubMed ID: 17668116
[TBL] [Abstract][Full Text] [Related]
16. Fractionated illumination after topical application of 5-aminolevulinic acid on normal skin of hairless mice: the influence of the dark interval.
de Bruijn HS; van der Ploeg-van den Heuvel A; Sterenborg HJ; Robinson DJ
J Photochem Photobiol B; 2006 Dec; 85(3):184-90. PubMed ID: 16945548
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of normal and balloon-injured rat carotid arteries using 5-amino-levulinic acid.
Nyamekye I; Anglin S; McEwan J; MacRobert A; Bown S; Bishop C
Circulation; 1995 Jan; 91(2):417-25. PubMed ID: 7805246
[TBL] [Abstract][Full Text] [Related]
18. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
19. Comparing desferrioxamine and light fractionation enhancement of ALA-PpIX photodynamic therapy in skin cancer.
de Souza AL; Marra K; Gunn J; Samkoe KS; Kanick SC; Davis SC; Chapman MS; Maytin EV; Hasan T; Pogue BW
Br J Cancer; 2016 Sep; 115(7):805-13. PubMed ID: 27575852
[TBL] [Abstract][Full Text] [Related]
20. 5-Aminolevulinic acid (ALA)-induced protoporphyrin IX fluorescence and photodynamic effects in the rat bladder: an in vivo study comparing oral and intravesical ALA administration.
Chang SC; Buonaccorsi G; MacRobert AJ; Bown SG
Lasers Surg Med; 1997; 20(3):254-64. PubMed ID: 9138254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
